Pyure Technology® is scientifically proven to rapidly and progressively kill SARS-CoV-2 (the virus that causes COVID-19) in air and on surfaces.
The outbreak of COVID-19 has had a dramatic impact worldwide, spreading by air, contaminated surfaces and personal contact. The risk of transmission in healthcare, schools, seniors homes, offices, commercial and industrial settings can be reduced by practicing personal safety measures and using Pyure Technology® to rapidly kill the SARS-CoV-2 virus in air and on surfaces.
Pyure Technology® reduces the viral load in the air by 99% in 20 minutes and below the limit of detection in 80 minutes, significantly reducing the risk of transmission. Pyure Technology®, when combined with personal safety measures, can help protect healthcare workers, patients, seniors, students, employees, and patrons.
Pyure uses ultraviolet (UV) energy to mimic the way sunlight sanitizes our outdoor environment by safely generating and diffusing hydroxyls and organic oxidants indoors. The hydroxyls react with volatile organic compounds (VOC) to generate powerful organic oxidants.
The study was designed and conducted by Innovative Bioanalysis LLC, a biosafety level 3 laboratory. The study demonstrated the efficacy of the Pyure device in destroying SARS-CoV-2, both in aerosolized form and on surfaces. Innovative Bioanalysis is certified laboratory located in Costa Mesa, Calif.
The Pyure device tested in the study was the MDU/Rx™ portable air purifier. The MDU/Rx™ is an FDA registered Class II medical device. For information on the MDU/Rx™visit our dedicated website learn more.
All Pyure products utilize the same hydroxyl and organic oxidant generating technology that is built into the MDU/Rx™.
Every effort was made to simulate a real-life environment in the testing chamber, while taking into consideration the special precautions needed when working in a Biosafety Level 3 pathogen.
The study was carried out in a large test chamber to simulate a real-life environment, The trials were conducted with a very high starting concentration of SARS-CoV-2 virus for aerosolization and surface inoculation, and were run in triplicate, with controls at every sampling time point.
Pyure undertook additional testing in the same test facility, using the same study design as the MDU/Rx™ trials, to confirm the efficacy of two other devices: the Slimline™ and the MySpace™.
The studies confirmed that the Slimline™ and MySpace™ kill the COVID-19 virus in air and on surfaces, with efficacy comparable to the MDU/Rx™.